Group 1: A-Share Market Overview - As of August 15, 2025, 505 A-share listed companies have disclosed their mid-year reports, with 106 companies showing private equity firms among their top ten circulating shareholders, collectively holding a market value of 25.164 billion yuan [1] Group 2: Hikvision (002415) Financial Performance - Hikvision reported a revenue of 41.818 billion yuan for the first half of 2025, representing a year-on-year growth of 1.48%, and a net profit attributable to shareholders of 5.657 billion yuan, up 11.71% year-on-year [2] - High Yi Asset has reduced its holdings in Hikvision, with its fund holding 338 million shares as of the end of Q2 2025, down by 12 million shares from the end of Q1 2025, resulting in a holding value of 9.373 billion yuan [2][3] Group 3: High Yi Asset's Investment Activities - High Yi Asset has continuously reduced its holdings in Hikvision for three consecutive quarters, totaling over 74 million shares since Q4 2024 [3] - In addition to Hikvision, High Yi Asset also reduced its stake in Dongcheng Pharmaceutical (002675), holding 17.5 million shares as of Q2 2025, down by 4 million shares, with a holding value of 252 million yuan [4] - High Yi Asset increased its holdings in Angel Yeast (600298) to 35 million shares by the end of Q2 2025, with a holding value of 1.231 billion yuan [4] Group 4: Other Private Equity Holdings - Freshwater Spring and Ying Shui Investment have disclosed their latest holdings, with Freshwater Spring holding 9.0333 million shares of Shengyi Technology (600183) valued at 272 million yuan, unchanged from Q1 2025 [5] - Ying Shui Investment holds shares in Yifan Pharmaceutical (002019), Sujiao Science (300284), and Hengwei Technology (603496), with a total of 24.67 million shares in Yifan Pharmaceutical valued at 321 million yuan, also unchanged from Q1 2025 [5] - Ying Shui Investment's funds are also present in Sujiao Science, holding 65.6691 million shares valued at 597 million yuan, with no change from Q1 2025 [5]

Core Viewpoint - The article highlights the recent disclosures of A-share listed companies' mid-year reports for 2025, revealing significant movements in private equity holdings, particularly the reduction of stakes by prominent private equity firms in companies like Hikvision and Dongcheng Pharmaceutical [1][2][3]. Group 1: A-share Listed Companies Mid-Year Reports - As of August 15, 2025, 505 A-share listed companies have disclosed their mid-year reports, with 106 companies showing private equity firms among their top ten shareholders, collectively holding a market value of 25.164 billion yuan [1]. - Hikvision reported a revenue of 41.818 billion yuan for the first half of 2025, reflecting a year-on-year growth of 1.48%, while net profit attributable to shareholders was 5.657 billion yuan, up 11.71% year-on-year [3]. Group 2: Hikvision Shareholding Changes - High Yi Asset has reduced its holdings in Hikvision, decreasing its shares by 12 million to 338 million, with a market value of 9.373 billion yuan as of the end of Q2 2025 [3][4]. - High Yi Asset has been consistently reducing its stake in Hikvision for three consecutive quarters, totaling over 74 million shares since Q4 2024 [4]. Group 3: Dongcheng Pharmaceutical Shareholding Changes - High Yi Asset also reduced its stake in Dongcheng Pharmaceutical, holding 17.5 million shares as of Q2 2025, down by 4 million shares, with a market value of 252 million yuan [5]. - The fund initially entered Dongcheng Pharmaceutical's top ten shareholders in Q2 2022 and had increased its holdings to 35 million shares before the recent reduction [5]. Group 4: Other Private Equity Movements - High Yi Asset increased its holdings in Angel Yeast, reaching 35 million shares with a market value of 1.231 billion yuan by the end of Q2 2025 [6]. - Other private equity firms, such as Danshuiquan and Ying Shui Investment, have also disclosed their major holdings, including investments in companies like Shengyi Technology and Yifan Pharmaceutical, with stable shareholding numbers compared to Q1 2025 [8][9].